Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:16:51 UTC |
---|
Last Updated | 2019-10-01 21:37:19 UTC |
---|
CypComp ID | CC00101 |
---|
Compound Information |
---|
Name | Thalidomide |
---|
Structure Image | |
---|
InChIKey | UEJJHQNACJXSKW-VIFPVBQESA-N |
---|
PubChem ID | 92142 |
---|
CypCompound Information |
---|
Set | CypReact Training Set |
---|
Reactant Statuses | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | Non-Reactant | Non-Reactant | Reactant | Non-Reactant | Reactant | Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
|
---|
References | - Ando Y, Fuse E, Figg WD: Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res. 2002 Jun;8(6):1964-73. [PubMed:12060642 ]
|
---|
Download File | CC00101.sdf |
---|